MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202511120822 A) filed by Meerut Institute Of Engineering & Technology, Meerut; Mr. Sunny; Mr. Yash Vardhan Bhardwaj; and Ms. Archana Adhana on December 02, 2025, for Medication Risk Evaluation System (mres).
Inventors include Mr. Sunny; Mr. Yash Vardhan Bhardwaj; and Ms. Archana Adhana.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: The invention relates to a computer-implemented Medication Risk Evaluation System (MRES) for predicting patient-specific adverse drug risks arising from polypharmacy. The system integrates multiple data inputs—patient demographics, medication details, organ impairments, and dosage—to compute a composite risk score through a structured algorithm. Key modules include patient data input (10), medication scoring (30), dosage analyzer (40), organ impairment adjustment (50), and risk aggregation (80). The output categorizes overall risk levels as low, moderate, or high, displayed via an interactive dashboard (100) and downloadable reports (110). By automating complex clinical evaluation, MRES significantly enhances medication safety, reduces adverse events, and supports evidence-based prescription management across healthcare systems.
Disclaimer: Curated by HT Syndication.
